MAEL and diffuse large B-cell lymphoma: We found that six RBPs, including CMSS1, MAEL, THOC5, PSIP1, SNIP1, and ZCCHC7, are significantly related to OS of DLBCL patients, which could potentially be served as prognostic biomarkers.